JOHNSON & JOHNSON UNIT ORTHONEUTROGENA ACQUIRES ISRAEL BASED COLBAR LIFESCIENCE FOR UNDISCLOSED SUM

Johnson & Johnson, a health care company, announced that OrthoNeutrogena, a division of Ortho-McNeil Pharmaceutical, Inc., a Johnson & Johnson company, has purchased privately held biotechnology company Colbar LifeScience Ltd., specializing in reconstructive medicine and tissue engineering.

Trading Markets (http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/302598/)